Literature DB >> 27606455

Which patent and where? Why international patent transparency by companies is needed for medicines.

Reed F Beall1, Amir Attaran1.   

Abstract

Mesh：

Year:  2016        PMID： 27606455     DOI： 10.1038/nbt.3664

Source DB:  PubMed          Journal:  Nat Biotechnol        ISSN： 1087-0156            Impact factor:   54.908


× No keyword cloud information.
  2 in total

1.  How do patents and economic policies affect access to essential medicines in developing countries?

Authors:  Amir Attaran
Journal:  Health Aff (Millwood)       Date:  2004 May-Jun       Impact factor: 6.301

2.  Patent and exclusivity status of essential medicines for non-communicable disease.

Authors:  Tim K Mackey; Bryan A Liang
Journal:  PLoS One       Date:  2012-11-30       Impact factor: 3.240
  2 in total
  2 in total

1.  In which developing countries are patents on essential medicines being filed?

Authors:  Reed F Beall; Rosanne Blanchet; Amir Attaran
Journal:  Global Health       Date:  2017-06-26       Impact factor: 4.185

2.  Analysis of the Factors Influencing Enterprise and Government Participation in the Medicines Patent Pool Based on System Dynamics Model.

Authors:  Jinjing Zeng; Wende Zhang; Qingming Tang
Journal:  Iran J Public Health       Date:  2018-10       Impact factor: 1.429
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.